CXXIF
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Sep 5 closing price
Capitalization
39.27M
TCNNF
Price
$7.58
Change
+$0.33 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.46B
60 days until earnings call
Interact to see
Advertisement

CXXIF vs TCNNF

Header iconCXXIF vs TCNNF Comparison
Open Charts CXXIF vs TCNNFBanner chart's image
C21 Investments
Price$0.34
Change+$0.02 (+6.25%)
Volume$41.22K
Capitalization39.27M
Trulieve Cannabis
Price$7.58
Change+$0.33 (+4.55%)
Volume$309.56K
Capitalization1.46B
CXXIF vs TCNNF Comparison Chart in %
Loading...
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CXXIF vs. TCNNF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CXXIF is a Hold and TCNNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CXXIF: $0.34 vs. TCNNF: $7.58)
Brand notoriety: CXXIF and TCNNF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CXXIF: 29% vs. TCNNF: 43%
Market capitalization -- CXXIF: $39.27M vs. TCNNF: $1.46B
CXXIF [@Pharmaceuticals: Generic] is valued at $39.27M. TCNNF’s [@Pharmaceuticals: Generic] market capitalization is $1.46B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CXXIF’s FA Score shows that 1 FA rating(s) are green whileTCNNF’s FA Score has 1 green FA rating(s).

  • CXXIF’s FA Score: 1 green, 4 red.
  • TCNNF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CXXIF and TCNNF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CXXIF’s TA Score shows that 3 TA indicator(s) are bullish while TCNNF’s TA Score has 4 bullish TA indicator(s).

  • CXXIF’s TA Score: 3 bullish, 5 bearish.
  • TCNNF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TCNNF is a better buy in the short-term than CXXIF.

Price Growth

CXXIF (@Pharmaceuticals: Generic) experienced а -20.33% price change this week, while TCNNF (@Pharmaceuticals: Generic) price change was -13.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

TCNNF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCNNF($1.46B) has a higher market cap than CXXIF($39.3M). CXXIF YTD gains are higher at: 70.500 vs. TCNNF (46.233). TCNNF has higher annual earnings (EBITDA): 280M vs. CXXIF (4.72M). TCNNF has more cash in the bank: 393M vs. CXXIF (2.66M). CXXIF has less debt than TCNNF: CXXIF (12.9M) vs TCNNF (824M). TCNNF has higher revenues than CXXIF: TCNNF (1.19B) vs CXXIF (32.1M).
CXXIFTCNNFCXXIF / TCNNF
Capitalization39.3M1.46B3%
EBITDA4.72M280M2%
Gain YTD70.50046.233152%
P/E RatioN/AN/A-
Revenue32.1M1.19B3%
Total Cash2.66M393M1%
Total Debt12.9M824M2%
FUNDAMENTALS RATINGS
CXXIF vs TCNNF: Fundamental Ratings
CXXIF
TCNNF
OUTLOOK RATING
1..100
7412
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
3637
P/E GROWTH RATING
1..100
716
SEASONALITY SCORE
1..100
n/a18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCNNF's Valuation (83) in the null industry is in the same range as CXXIF (98). This means that TCNNF’s stock grew similarly to CXXIF’s over the last 12 months.

TCNNF's Profit vs Risk Rating (100) in the null industry is in the same range as CXXIF (100). This means that TCNNF’s stock grew similarly to CXXIF’s over the last 12 months.

TCNNF's SMR Rating (94) in the null industry is in the same range as CXXIF (94). This means that TCNNF’s stock grew similarly to CXXIF’s over the last 12 months.

CXXIF's Price Growth Rating (36) in the null industry is in the same range as TCNNF (37). This means that CXXIF’s stock grew similarly to TCNNF’s over the last 12 months.

CXXIF's P/E Growth Rating (7) in the null industry is in the same range as TCNNF (16). This means that CXXIF’s stock grew similarly to TCNNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CXXIFTCNNF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLUIX29.58N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val I
NSCCX39.82N/A
N/A
Nuveen Small-Cap Value Opps C
MGLRX16.64N/A
N/A
MFS Global Real Estate R6
NGJFX19.11N/A
N/A
Nuveen Global Real Estate Securities R6
MSJFX65.96N/A
N/A
Invesco Main Street R5

CXXIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CXXIF has been loosely correlated with GTBIF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CXXIF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CXXIF
1D Price
Change %
CXXIF100%
+6.76%
GTBIF - CXXIF
54%
Loosely correlated
+4.55%
TCNNF - CXXIF
53%
Loosely correlated
+4.55%
VRNOF - CXXIF
52%
Loosely correlated
+5.51%
TSNDF - CXXIF
52%
Loosely correlated
+13.08%
JUSHF - CXXIF
47%
Loosely correlated
+6.59%
More

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+4.55%
GTBIF - TCNNF
83%
Closely correlated
+4.55%
CURLF - TCNNF
80%
Closely correlated
+1.79%
VRNOF - TCNNF
76%
Closely correlated
+5.51%
TSNDF - TCNNF
76%
Closely correlated
+13.08%
CRLBF - TCNNF
75%
Closely correlated
+5.26%
More